Ramona Hagler
Duesseldorf, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
From measurement to biomarker trajectories: platform-agnostic Z score analysis of serum NfL and GFAP in ocrelizumab-treated multiple sclerosis.
Journal: Journal of neurology
Published: March 23, 2026
Rethinking EDSS-based ambulation assessment in multiple sclerosis using continuous variable monitoring.
Journal: Neurological research and practice
Published: February 24, 2026
Investigating the role of serum IL-6 in predicting outcomes of b-cell depleting therapy in multiple sclerosis: a retrospective cohort study.
Journal: BMC neurology
Published: February 15, 2026
Brain age gap in multiple sclerosis: associated with disability but independent of serum biomarkers.
Brain age gap in multiple sclerosis: associated with disability but independent of serum biomarkers.
Journal: Therapeutic advances in neurological disorders
Published: January 18, 2026
Serum levels of neurofilament light chain (NfL) and glial fibrillary acid protein (GFAP) in patients with asymptomatic and symptomatic carotid artery stenosis.
Journal: JVS-vascular science
Published: November 13, 2025
Case-Based Lessons on Remote Patient Monitoring in Neurology Using Consumer-Grade Wearables.
Journal: Journal of central nervous system disease
Published: August 14, 2025
Association of body mass index and clinical response in patients receiving ofatumumab for treatment of multiple sclerosis.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: December 16, 2024
Flow cytometry identifies changes in peripheral and intrathecal lymphocyte patterns in CNS autoimmune disorders and primary CNS malignancies.
Journal: Journal of neuroinflammation
Published: September 15, 2024
Showing 1-9 of 9
Last Updated: 09/26/2026